tradingkey.logo

Propanc Biopharma Ord Shs

PPCB
0.711USD
-0.009-1.25%
Close 12/19, 16:00ETQuotes delayed by 15 min
9.47MMarket Cap
0.03P/E TTM
You can access the annual and quarterly cash flow statements of Propanc Biopharma Ord Shs to evaluate its financial soundness and stability.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
---1.94M
Net income from continuing operations
---4.84M
Operating gains losses
--125.00
Other non-cash items
--3.79M
Change in working capital
---907.69K
-Change in receivables
---3.04K
-Change in prepaid expenses
---362.33K
-Change in other current assets
---7.44K
Cash from non-recurring investing activities
Cash from operating activities
---1.94M
Investing cash flow
Net cash from continuing investing activities
--2.49K
Capital expenditures
--2.49K
Net cash flow from disposal of fixed assets
--2.49K
Cash from non-current investing activities
Net cash flow from investing activities
---2.49K
Financing cash flow
Cash flow from continuous financing activities
--2.53M
Net cash flow from debt Issuance/repayment
---772.69K
Net cash flow from common stock issuance/repurchase
--3.31M
Net cash flow from other financing activities
---15.00K
Net cash from non-recurrent financing activities
Net cash from financing activities
--2.53M
Net cash flow
Beginning cash balance
--12.09K
Current period cash flow changes
--590.65K
Effect of exchange rate changes
--5.43K
Ending cash balance
--602.74K
Free cash flow
---1.94M
Currency unit
USD
Audit opinions
--

FAQs

What is the cash flow statement?

This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.
KeyAI